These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7338703)

  • 1. An assessment of efficiency in potential screening for Wilson's disease.
    Saito T
    J Epidemiol Community Health; 1981 Dec; 35(4):274-80. PubMed ID: 7338703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
    Merle U; Eisenbach C; Weiss KH; Tuma S; Stremmel W
    J Hepatol; 2009 Nov; 51(5):925-30. PubMed ID: 19720421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population screening for Wilson's disease.
    Hahn SH
    Ann N Y Acad Sci; 2014 May; 1315():64-9. PubMed ID: 24731025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass screening for Wilson's disease: results and recommendations.
    Yamaguchi Y; Aoki T; Arashima S; Ooura T; Takada G; Kitagawa T; Shigematsu Y; Shimada M; Kobayashi M; Itou M; Endo F
    Pediatr Int; 1999 Aug; 41(4):405-8. PubMed ID: 10453195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Families with Wilson's disease in subsequent generations: clinical and genetic analysis.
    Dzieżyc K; Litwin T; Chabik G; Gramza K; Członkowska A
    Mov Disord; 2014 Dec; 29(14):1828-32. PubMed ID: 25327413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A screening test for Wilson's disease and its application to psychiatric patients.
    Cox DW
    Can Med Assoc J; 1967 Jan; 96(2):83-6. PubMed ID: 6017170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 9. Caeruloplasmin isoforms in Wilson's disease in neonates.
    Chowrimootoo GF; Scowcroft H; Seymour CA
    Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F198-201. PubMed ID: 10194991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular studies of ceruloplasmin deficiency in Wilson's disease.
    Czaja MJ; Weiner FR; Schwarzenberg SJ; Sternlieb I; Scheinberg IH; Van Thiel DH; LaRusso NF; Giambrone MA; Kirschner R; Koschinsky ML
    J Clin Invest; 1987 Oct; 80(4):1200-4. PubMed ID: 3654978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilson's disease in two consecutive generations: the detection of three mutated alleles in the ATP7B gene in two Sardinian families.
    Loudianos G; Zappu A; Lepori MB; Incollu S; Dessì V; Mameli E; Garrucciu G; De Virgiliis S; Cao A
    Dig Liver Dis; 2013 Apr; 45(4):342-5. PubMed ID: 23219664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of mass screening for Wilson's disease in Korea.
    Hahn SH; Lee SY; Jang YJ; Kim SN; Shin HC; Park SY; Han HS; Yu ES; Yoo HW; Lee JS; Chung CS; Lee SY; Lee DH
    Mol Genet Metab; 2002 Jun; 76(2):133-6. PubMed ID: 12083810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
    Walshe JM;
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):115-21. PubMed ID: 12662398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass screening for Wilson's disease by measuring urinary holoceruloplasmin.
    Owada M; Suzuki K; Fukushi M; Yamauchi K; Kitagawa T
    J Pediatr; 2002 May; 140(5):614-6. PubMed ID: 12032531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wilson's disease--a factor in the differential diagnosis in hepatopathies].
    Dastych M; Jezek P; Snelerová M
    Vnitr Lek; 1989 Jul; 35(7):695-700. PubMed ID: 2800377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilson's disease: diagnostic difficulties in the patient with chronic hepatitis and hypoceruloplasminemia.
    Spechler SJ; Koff RS
    Gastroenterology; 1980 Apr; 78(4):803-6. PubMed ID: 7353765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Wilson's disease: about a family case].
    Mouzari Y; Abdelkhalek R; El Asri F; Reda K; Oubaaz A
    Pan Afr Med J; 2014; 18():270. PubMed ID: 25426217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
    Gollan JL; Stocks J; Dormandy TL; Sherlock S
    J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.